BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12512034)

  • 1. Progression of fibrosis in chronic hepatitis C.
    Ghany MG; Kleiner DE; Alter H; Doo E; Khokar F; Promrat K; Herion D; Park Y; Liang TJ; Hoofnagle JH
    Gastroenterology; 2003 Jan; 124(1):97-104. PubMed ID: 12512034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of liver fibrosis and cirrhosis in a nationwide sample of organ donors with liver histology.
    Åberg F; Savikko J; Eerola V; Nordin A; Isoniemi H
    J Hepatol; 2024 May; 80(5):e205-e207. PubMed ID: 37813245
    [No Abstract]   [Full Text] [Related]  

  • 3. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression.
    Thein HH; Yi Q; Dore GJ; Krahn MD
    Hepatology; 2008 Aug; 48(2):418-31. PubMed ID: 18563841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.
    Poynard T; Bedossa P; Opolon P
    Lancet; 1997 Mar; 349(9055):825-32. PubMed ID: 9121257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study.
    Ryder SD; Irving WL; Jones DA; Neal KR; Underwood JC;
    Gut; 2004 Mar; 53(3):451-5. PubMed ID: 14960533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fibrosis.
    Bataller R; Brenner DA
    J Clin Invest; 2005 Feb; 115(2):209-18. PubMed ID: 15690074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Surgeons Reliably Identify Non-cirrhotic Liver Disease During Laparoscopic Bariatric Surgery?
    Wuopio A; Baker BM; Koethe B; Goodman MD; Shin R; Bugaev N; Nepomnayshy D; Kim WC; Schnelldorfer T
    Obes Surg; 2024 Mar; 34(3):769-777. PubMed ID: 38280161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches.
    Mohammed OS; Attia HG; Mohamed BMSA; Elbaset MA; Fayed HM
    J Pharm Pharm Sci; 2023; 26():11808. PubMed ID: 38022905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital pathology for nonalcoholic steatohepatitis assessment.
    Sanyal AJ; Jha P; Kleiner DE
    Nat Rev Gastroenterol Hepatol; 2024 Jan; 21(1):57-69. PubMed ID: 37789057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A standardized pomegranate fruit extract ameliorates thioacetamide-induced liver fibrosis in rats via AGE-RAGE-ROS signaling.
    Abouelezz HM; Shehatou GSG; Shebl AM; Salem HA
    Heliyon; 2023 Mar; 9(3):e14256. PubMed ID: 36938469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital Pathology Enables Automated and Quantitative Assessment of Inflammatory Activity in Patients with Chronic Liver Disease.
    Marti-Aguado D; Fernández-Patón M; Alfaro-Cervello C; Mestre-Alagarda C; Bauza M; Gallen-Peris A; Merino V; Benlloch S; Pérez-Rojas J; Ferrández A; Puglia V; Gimeno-Torres M; Aguilera V; Monton C; Escudero-García D; Alberich-Bayarri Á; Serra MA; Marti-Bonmati L
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of silybin supplementation on nutrient digestibility, hematological parameters, liver function indices, and liver-specific mi-RNA concentration in dogs.
    Gogulski M; Cieślak A; Grabska J; Ardois M; Pomorska-Mól M; Kołodziejski PA; Libera K; Strompfová V; Szumacher-Strabel M
    BMC Vet Res; 2021 Jun; 17(1):228. PubMed ID: 34174886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic Effect of Barbadensis miller and Marsdenia Condurango Extracts Induces Apoptosis Promotes Oxidative Stress by Limiting Proliferation of Cervical Cancer and Liver Cancer Cells.
    Maqbool T; Hadi F; Razzaq S; Naz S; Aftab S; Khurshid S; Awan SJ; Nawaz A; Abid F; Malik A
    Asian Pac J Cancer Prev; 2021 Mar; 22(3):843-852. PubMed ID: 33773549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection.
    El-Mowafy M; Elgaml A; El-Mesery M; Sultan S; Ahmed TAE; Gomaa AI; Aly M; Mottawea W
    Biology (Basel); 2021 Jan; 10(1):. PubMed ID: 33451143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis.
    Graf C; Welzel T; Bogdanou D; Vermehren J; Beckel A; Bojunga J; Friedrich-Rust M; Dietz J; Kubesch A; Mondorf A; Fischer S; Lutz T; Stoffers P; Herrmann E; Poynard T; Zeuzem S; Dultz G; Mihm U
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32825571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver-related effects of chronic hepatitis C antiviral treatment.
    Laursen TL; Sandahl TD; Kazankov K; George J; Grønbæk H
    World J Gastroenterol; 2020 Jun; 26(22):2931-2947. PubMed ID: 32587440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma.
    Sojoodi M; Wei L; Erstad DJ; Yamada S; Fujii T; Hirschfield H; Kim RS; Lauwers GY; Lanuti M; Hoshida Y; Tanabe KK; Fuchs BC
    Cancer Prev Res (Phila); 2020 Jun; 13(6):497-508. PubMed ID: 32253266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis.
    Schwabe RF; Tabas I; Pajvani UB
    Gastroenterology; 2020 May; 158(7):1913-1928. PubMed ID: 32044315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis.
    Khatun M; Ray RB
    Cells; 2019 Oct; 8(10):. PubMed ID: 31615075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis.
    Li X; Jiao Y; Xing Y; Gao P
    Biomed Res Int; 2019; 2019():5308308. PubMed ID: 31080822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.